BMCG assists client companies in solving problems like these..
“ Where can I find pharma-exclusive experts who are organized like a pharmaceutical company?”
“… a collaborative group with a history of working together for my benefit?”
“… that make me and my company their top priority?”
“… that know when to take on a project, as well as when to refer me to someone else ”
“… that understand the important issues of a small company”
How is it we know what it is like to sit in your chair?
Paul F. Duffy, Managing Principal
Mr. Duffy brings Black Mountain Consulting Group extensive experience at both big pharma and start-up organizations. He acquired more than 30 years of big pharma experience at Novartis Pharmaceuticals (formerly Sandoz Pharmaceuticals), having held sales and marketing positions of increasing responsibility from 1972 to 2003, when he served as U.S. National Sales Director-Neuroscience. Mr. Duffy then left Novartis to co-found CNS start-up Alamo Pharmaceuticals, where he served as Executive Vice President. At Alamo, he created a fully integrated commercial pharmaceutical company to market Fazaclo, a patented reformulation of Novartis' anti-psychotic drug, Clozaril. Duffy left Alamo in July 2006, after completing its sale to Avanir Pharmaceuticals. He then became founding CEO of Validus Pharmaceuticals, creating an entirely new type of private-equity backed pharmaceutical company. Most recently, Duffy served as President -US Commercial Operations for the UK-based multinational, Amarin Pharmaceuticals.
Josh Weinstein, Principal
For the past 12 years Weinstein has served as President of jwEinstein Strategic Messaging, Inc., an advertising, PR, and advocacy development company specialized in helping young pharma and device companies. Mr. Weinstein’s career began at Sandoz Pharmaceuticals (now Novartis) where he developed the launch campaigns for Tavist and Visken. Weinstein then joined Schering-Plough where, as Director of Marketing, he launched Normodyne and Intron-A (alfa-interferon)--now a multi-billion dollar product. After moving to Schering International, to manage their cardiovascular market development, he was recruited by Squibb to be Vice President of Marketing, USA and to manage the development of Pravachol (one of the nation’s first ‘statins’). Weinstein was later recruited to run the New York Healthcare practice of the prestigious public relations firm, Hill & Knowlton, and went on to become Executive Vice President in PR giant, Burson-Marstellar’s Washington, DC and New York healthcare operations. Subsequently, Mr. Weinstein was recruited by McCann-Erickson’s Torre-Lazur and Weber divisions where he became Founding President of Torre Lazur/Weber, and the Torre-Lazur/McCann Global Advocacy Group.
Because we’ve done it. Mike Leone, Principal Mike Leone is recognized as an accomplished pharmaceutical executive with broad therapeutic expertise. His over 25 years of experience and leadership includes positions of increasing senior level responsibility at Bristol-Myers Squibb, First Horizon Pharmaceuticals, Eyetech Pharmaceuticals and Takeda Pharmaceuticals North America. Mike is currently President of Strategic HealthCare Resources, LLC, and is consulting for a number of venture capital, pharmaceutical, biotech and device companies. He has helped companies create sales force deployment models, developed compensation models, served as a direct customer liaison with state Medicaid and federal government customers on formulary and pharmacoeconomic issues, consulted on clinical trial focus areas, conducted focused leadership training programs, and counseled a growing sales organization on how to enhance the structure of its organization and improve the capabilities of its leaders. Having spent the majority of his career at Bristol-Myers Squibb, Mr. Leone held numerous positions of increasing responsibility. These positions included National Director, Federal & Institutional Sales, a position in which he rebuilt the Hospital Sales Team and strengthened BMS’ role and commitment to VA and military customers. In that role, Mike spearheaded the institutional launches of Maxipime and Plavix. Mike’s National Accounts experience, and focused, field-based hospital sales leadership expertise have made him an especially valuable asset to Specialty Pharma clients.
Four Key Business Components Strategic Consulting Tactical Implementation Pharma Services Subject Experts
Strategic Consulting: We provide business strategy development for addressing key challenges across the organization and brand life cycle. Capabilities include corporate business and brand strategy, from early stage clinical and regulatory development through successful commercialization.
Tactical Implementation: We bring your strategy to life by doing the work that you may not be staffed to do. Our collaborative strength is in all phases of Clinical, Commercial and Corporate/Operational projects, designed to place a carefully matched professional to your needs.
Ask Our Experts: As a BMCG client , you can quickly access subject area experts via a brief teleconference, in situations where you may only need some quick advice or a second opinion. Choose the expert from our team who most closely matches your issue or opportunity and dial-in to a solution.
BMCG Pharma Services: … are pharma dedicated and proven service experts in their field. We know because we worked shoulder to shoulder with them. BMCG invites only those proven to deliver results. They have proven their mettle to us; let us show you how they can deliver for you!
Four Key Business Components
BMCG’s Seven Service Groups… We organize like a Pharma company, focusing on critical company functions : Business Development Pharma Services Corporate Operations Medical, Legal and Regulatory Distribution & Trade Marketing Strategy, Services & Support Sales
This Presentation is Confidential and is not Authorized for Reproduction ,Electronic Transmission ,in whole or in part, without the Prior written Permission of a Principal of the Black Mountain Consulting Group.